유럽의 장기 보존 용액 시장 : 예측 - 지역별 분석 - 제품, 용도, 유형, 최종 사용자별(-2031년)

The Europe organ preservation solution market was valued at US$ 86,522.54 thousand in 2023 and is expected to reach US$ 1,59,990.22 thousand by 2031; it is estimated to register a CAGR of 8.1% from 2024 to 2031.

Increasing Prevalence of Chronic Disease Fuels Europe Organ Preservation Solution Market

Chronic diseases, which may be congenital or acquired, can lead to gradual damage to organs over time. A chronic disease typically does not resolve on its own, but there may be ways to slow down the damage caused by the condition. It may take decades for this damage to build up to the point where it noticeably affects patients' organ function or requires medical intervention. Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately 1 in every 10 people worldwide. Chronic liver diseases such as fatty liver disease and hepatitis C are the common causes of chronic liver failure. The World Health Organization (WHO) estimates that ~50 million people are living with chronic hepatitis C virus infection worldwide, with approximately 1.0 million new infections occurring each year. In 2022, ~242,000 people died from hepatitis C, mainly due to cirrhosis and hepatocellular carcinoma. Chronic heart diseases, including coronary artery disease and congenital heart disease, can lead to progressive heart failure. According to the Global Heart & Circulatory Diseases Factsheet by the British Heart Foundation, congenital heart disease is a rapidly emerging problem in child health worldwide. It is diagnosed in approximately 1 in 110 births globally, and the diagnoses later in the lives of babies may reach as high as 1.2 million per year, averaging 3,300 per day (or a diagnosis every 26 seconds). Thus, the demand for organ preservation solutions increases with a surge in the need for availability of chronic disease-related organ transplantation procedures.

Europe Organ Preservation Solution Market Overview

The Europe organ preservation solution market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany and Italy are expected to account for a significant market share in the regional market during the forecast period. The market in France, the UK, and Spain is likely to experience lucrative opportunities in the coming years. The growing number of organ transplantations, rising prevalence of chronic diseases that lead to organ failure, and technological advancements in organ preservation solutions drive the organ preservation solution market growth in Europe. Germany is expected to be among the major contributors to the growth of the organ preservation solution market in worldwide. As per the "World Population Ageing," nearly 28.0% of the total population of Germany was aged 60 and above in 2017, and the aging population is estimated to rise to nearly 37.6% by 2050. The prevalence of chronic diseases increases with age. Also, with growing age, many organs start to malfunction or become dysfunctional, giving rise to the demand for organ transplantation procedures. Thus, with the rising geriatric population, the demand for organ preservation solutions is growing.

Europe Organ Preservation Solution Market Revenue and Forecast to 2031 (US$ Thousand)

Europe Organ Preservation Solution Market Segmentation

The Europe organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the Europe organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the Europe organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the Europe organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the Europe organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the Europe organ preservation solution market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe organ preservation solution market share in 2023.

XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, and Accord Healthcare, are among the leading companies operating in the Europe organ preservation solution market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights
• 2.2 Market Attractiveness

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Organ Preservation Solution Market - Key Market Dynamics

• 4.1 Market Drivers
  • 4.1.1 Rising Need for Organ Transplantation
  • 4.1.2 Increasing Prevalence of Chronic Diseases
• 4.2 Market Restraints
  • 4.2.1 Expensive Organ Transplant Surgeries
  • 4.2.2 Limited Organ Availability
• 4.3 Market Opportunities
  • 4.3.1 Strategic Initiatives by Market Players
• 4.4 Future Trends
  • 4.4.1 Shift Toward Machine Perfusion Technique
• 4.5 Impact of Drivers and Restraints:

5. Organ Preservation Solution Market - Europe Analysis

• 5.1 Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
• 5.2 Organ Preservation Solution Market forecast Analysis

6. Europe Organ Preservation Solution Market Analysis - by Product

• 6.1 University of Wisconsin Solution
  • 6.1.1 Overview
  • 6.1.2 University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 6.2 Custodiol HTK
  • 6.2.1 Overview
  • 6.2.2 Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 6.3 Perfadex
  • 6.3.1 Overview
  • 6.3.2 Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 6.4 HypoThermosol
  • 6.4.1 Overview
  • 6.4.2 HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 6.5 Others
  • 6.5.1 Overview
  • 6.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

7. Europe Organ Preservation Solution Market Analysis - by Application

• 7.1 Static Cold Storage
  • 7.1.1 Overview
  • 7.1.2 Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 7.2 Hypothermic Machine Perfusion
  • 7.2.1 Overview
  • 7.2.2 Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 7.3 Normothermic Machine Perfusion
  • 7.3.1 Overview
  • 7.3.2 Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 7.4 Others
  • 7.4.1 Overview
  • 7.4.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

8. Europe Organ Preservation Solution Market Analysis - by Type

• 8.1 Kidneys
  • 8.1.1 Overview
  • 8.1.2 Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 8.2 Liver
  • 8.2.1 Overview
  • 8.2.2 Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 8.3 Lungs
  • 8.3.1 Overview
  • 8.3.2 Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 8.4 Heart
  • 8.4.1 Overview
  • 8.4.2 Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 8.5 Others
  • 8.5.1 Overview
  • 8.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

9. Europe Organ Preservation Solution Market Analysis - by End User

• 9.1 Organ Transplant Centers
  • 9.1.1 Overview
  • 9.1.2 Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 9.2 Hospitals
  • 9.2.1 Overview
  • 9.2.2 Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
• 9.3 Specialty Clinics
  • 9.3.1 Overview
  • 9.3.2 Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

10. Europe Organ Preservation Solution Market - Country Analysis

• 10.1 Europe Organ Preservation Solution Market Overview
  • 10.1.1 Europe: Organ Preservation Solution Market Breakdown, by Key Country, 2023 and 2031 (%)
    • 10.1.1.1 Europe: Organ Preservation Solution Market - Revenue and forecast Analysis - by Country
    • 10.1.1.2 Germany: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
      • 10.1.1.2.1 Germany: Organ Preservation Solution Market Breakdown, by Product
      • 10.1.1.2.2 Germany: Organ Preservation Solution Market Breakdown, by Application
      • 10.1.1.2.3 Germany: Organ Preservation Solution Market Breakdown, by Type
      • 10.1.1.2.4 Germany: Organ Preservation Solution Market Breakdown, by End User
    • 10.1.1.3 United Kingdom: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
      • 10.1.1.3.1 United Kingdom: Organ Preservation Solution Market Breakdown, by Product
      • 10.1.1.3.2 United Kingdom: Organ Preservation Solution Market Breakdown, by Application
      • 10.1.1.3.3 United Kingdom: Organ Preservation Solution Market Breakdown, by Type
      • 10.1.1.3.4 United Kingdom: Organ Preservation Solution Market Breakdown, by End User
    • 10.1.1.4 France: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
      • 10.1.1.4.1 France: Organ Preservation Solution Market Breakdown, by Product
      • 10.1.1.4.2 France: Organ Preservation Solution Market Breakdown, by Application
      • 10.1.1.4.3 France: Organ Preservation Solution Market Breakdown, by Type
      • 10.1.1.4.4 France: Organ Preservation Solution Market Breakdown, by End User
    • 10.1.1.5 Italy: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
      • 10.1.1.5.1 Italy: Organ Preservation Solution Market Breakdown, by Product
      • 10.1.1.5.2 Italy: Organ Preservation Solution Market Breakdown, by Application
      • 10.1.1.5.3 Italy: Organ Preservation Solution Market Breakdown, by Type
      • 10.1.1.5.4 Italy: Organ Preservation Solution Market Breakdown, by End User
    • 10.1.1.6 Spain: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
      • 10.1.1.6.1 Spain: Organ Preservation Solution Market Breakdown, by Product
      • 10.1.1.6.2 Spain: Organ Preservation Solution Market Breakdown, by Application
      • 10.1.1.6.3 Spain: Organ Preservation Solution Market Breakdown, by Type
      • 10.1.1.6.4 Spain: Organ Preservation Solution Market Breakdown, by End User
    • 10.1.1.7 Rest of Europe: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
      • 10.1.1.7.1 Rest of Europe: Organ Preservation Solution Market Breakdown, by Product
      • 10.1.1.7.2 Rest of Europe: Organ Preservation Solution Market Breakdown, by Application
      • 10.1.1.7.3 Rest of Europe: Organ Preservation Solution Market Breakdown, by Type
      • 10.1.1.7.4 Rest of Europe: Organ Preservation Solution Market Breakdown, by End User

11. Organ Preservation Solutions Market - Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in Organ Preservation Solutions Market
• 11.3 Organic Growth Strategies
  • 11.3.1 Overview
• 11.4 Inorganic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 XVIVO Perfusion
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 TransMedics
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 OrganOx Limited
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Paragonix Technologies, Inc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Dr. Franz Koehler Chemie GmbH
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Accord Healthcare
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments

13. Appendix

• 13.1 About The Insight Partners
• 13.2 Glossary of Terms